Literature DB >> 15749841

IL-10-independent STAT3 activation by Toxoplasma gondii mediates suppression of IL-12 and TNF-alpha in host macrophages.

Barbara A Butcher1, Leesun Kim, Athanasia D Panopoulos, Stephanie S Watowich, Peter J Murray, Eric Y Denkers.   

Abstract

Infection of mouse macrophages by Toxoplasma gondii renders the cells resistant to proinflammatory effects of LPS triggering. In this study, we show that cell invasion is accompanied by rapid and sustained activation of host STAT3. Activation of STAT3 did not occur with soluble T. gondii extracts or heat-killed tachyzoites, demonstrating a requirement for live parasites. Parasite-induced STAT3 phosphorylation and suppression of LPS-triggered TNF-alpha and IL-12 was intact in IL-10-deficient macrophages, ruling out a role for this anti-inflammatory cytokine in the suppressive effects of T. gondii. Most importantly, Toxoplasma could not effectively suppress LPS-triggered TNF-alpha and IL-12 synthesis in STAT3-deficient macrophages. These results demonstrate that T. gondii exploits host STAT3 to prevent LPS-triggered IL-12 and TNF-alpha production, revealing for the first time a molecular mechanism underlying the parasite's suppressive effect on macrophage proinflammatory cytokine production.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15749841     DOI: 10.4049/jimmunol.174.6.3148

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  70 in total

Review 1.  An inside job: hacking into Janus kinase/signal transducer and activator of transcription signaling cascades by the intracellular protozoan Toxoplasma gondii.

Authors:  Eric Y Denkers; David J Bzik; Barbara A Fox; Barbara A Butcher
Journal:  Infect Immun       Date:  2011-11-21       Impact factor: 3.441

2.  Toxoplasma co-opts host gene expression by injection of a polymorphic kinase homologue.

Authors:  J P J Saeij; S Coller; J P Boyle; M E Jerome; M W White; J C Boothroyd
Journal:  Nature       Date:  2006-12-20       Impact factor: 49.962

Review 3.  Subversion of innate and adaptive immune responses by Toxoplasma gondii.

Authors:  Christine Lang; Uwe Gross; Carsten G K Lüder
Journal:  Parasitol Res       Date:  2006-10-06       Impact factor: 2.289

4.  Toxoplasma gondii inhibits toll-like receptor 4 ligand-induced mobilization of intracellular tumor necrosis factor alpha to the surface of mouse peritoneal neutrophils.

Authors:  Soumaya Bennouna; Woraporn Sukhumavasi; Eric Y Denkers
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

5.  IL-4 independent nuclear translocalization of STAT6 in HeLa cells by entry of Toxoplasma gondii.

Authors:  Hye-Jin Ahn; Ji Yeon Kim; Ho-Woo Nam
Journal:  Korean J Parasitol       Date:  2009-05-27       Impact factor: 1.341

6.  Toxoplasma gondii rhoptry discharge correlates with activation of the early growth response 2 host cell transcription factor.

Authors:  Eric D Phelps; Kristin R Sweeney; Ira J Blader
Journal:  Infect Immun       Date:  2008-08-04       Impact factor: 3.441

Review 7.  Functional aspects of Toll-like receptor/MyD88 signalling during protozoan infection: focus on Toxoplasma gondii.

Authors:  C E Egan; W Sukhumavasi; B A Butcher; E Y Denkers
Journal:  Clin Exp Immunol       Date:  2009-01-21       Impact factor: 4.330

8.  Cell invasion and strain dependent induction of suppressor of cytokine signaling-1 by Toxoplasma gondii.

Authors:  Andrea Stutz; Henning Kessler; Mariel-Esther Kaschel; Markus Meissner; Alexander H Dalpke
Journal:  Immunobiology       Date:  2011-08-27       Impact factor: 3.144

9.  Suppressed production of pro-inflammatory cytokines by LPS-activated macrophages after treatment with Toxoplasma gondii lysate.

Authors:  Eun-Jung Lee; Yoo-Mi Heo; Jong-Hak Choi; Hyun-Ouk Song; Jae-Sook Ryu; Myoung-Hee Ahn
Journal:  Korean J Parasitol       Date:  2008-09       Impact factor: 1.341

10.  Toxoplasma gondii Inactivates Human Plasmacytoid Dendritic Cells by Functional Mimicry of IL-10.

Authors:  Piotr L Pierog; Yanlin Zhao; Sukhwinder Singh; Jihong Dai; George S Yap; Patricia Fitzgerald-Bocarsly
Journal:  J Immunol       Date:  2017-11-27       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.